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Hepatocellular carcinoma (HCC) is a major public health concern in Sub-Saharan Africa. Early research in Ivory Coast
showed that chronic hepatitis B and aflatoxin B1 exposure were the two most important etiological agents of HCC
in the country but, surprisingly, no survey analyzing HCC etiologies has been conducted since decades.
In a preliminary report, we characterized for hepatitis B and C markers 30 consecutive cases of HCC recruited from
Abidjan hospitals between June 2011 and December 2012. Nutritional and lifestyle features of patients were analyzed
as well. The mean age of the patients was 53 ± 15 years with a sex ratio (M:F = 2.7). HBsAg was the most frequent viral
marker in the series (63 %). All HBV isolates belonged to genotype E. With regards to regional standard, anti-HCV
reached a very high level (47 %) in the present series. Hepatitis C was more frequent among patients living outside
Abidjan (83 vs 23 %, P = 0.009). Patients living in Abidjan were significantly younger than individual living elsewhere in
the country (48 ± 14 vs 60 ± 16 years old, P = 0.038) reflecting a possible role for local environmental pollution in tumor
progression. Finally, we observed that patients born in Mandé/Gur-speaking regions (North) were younger (48 ± 14 vs
59 ± 15, P = 0.05) and consumed maize more frequently (80 vs 26 %, P = 0.009) than other patients. Interestingly, maize
consumption was associated with a trend for aminotransferases elevation (mean = 1.7-1.8 fold, P = 0.06) suggesting a
direct hepatic toxicity of this staple food in Ivory Coast. In conclusion, our work indicates that HCC epidemiology
underwent recently major drifts in Ivory Coast.
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Early reports from Africa noted the frequent occurrence
of hepatocellular carcinoma (HCC) and this disease re-
mains one of the most common cancers on this contin-
ent [1]. Chronic infections with hepatitis B virus (HBV)
or hepatitis C virus (HCV) are known to be major etio-
logical factors of liver cancer worldwide including Sub-
Saharan Africa. Half of incident HCC cases worldwide
are still attributable to HBV [2]. Among others, an im-
portant risk factor of liver carcinogenesis in Africa is the* Correspondence: alphonsinembengue@pasteur.ci
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creativecommons.org/publicdomain/zero/1.0/aflatoxin B1 (AFB1), a mycotoxin known to frequently
contaminate staple food in the inter-tropical regions [3].
HBV is a partially double–stranded DNA virus and one
of the most important causes of morbidity and mortality
worldwide [4]. Globally, it is estimated that about two bil-
lion people have been infected with HBV and about 350
million people are chronically infected [5]. Areas with
highest HBV prevalence include Eastern Asia and Sub-
Saharan Africa, where approximately 10 % of the popula-
tions are chronic carriers [6]. In Sub-Saharan Africa,
high–risk groups for HBV infection include children
born from hepatitis B surface antigen (HBsAg) positive
mothers, intravenous drug users, individuals with high-
risk sexual behaviors including homosexual men, patients
undergoing hemodialysis and health care workers [6–8].s article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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infects 130–210 million people worldwide and at least
one third of HCC cases are attributed to HCV infection.
There are many geographical variations in HCV chronic
carriage due to the heterogeneity of risk factor preva-
lence between countries. HCV infection usually occurs
following direct parenteral exposure to contaminated
body fluids, especially blood [9]. High rates of chronic
infections have been historically related to inappropriate
medical practices as in Egypt or Japan where massive
anti-bilharzial prophylactic campaigns led to widespread
contaminations [10, 11]. In Sub-Saharan Africa, the
prevalence of chronic hepatitis C in the general population
is rather low except in selected countries from Central
Africa (Cameroun, Rwanda). Contamination with HCV re-
sults in chronic infection in 75–80 % of cases and a signifi-
cant subset of patients evolve toward liver cirrhosis and
HCC [12, 13]. The yearly risk of developing HCC ranges
from 1 to 5 % after two decades of chronic infection [12].
Overall, the role of HCV in the epidemiology of HCC in
Sub-Saharan Africa is rather poorly documented.
Aflatoxins are mycotoxins of the furanocoumarins
group that are common staple food contaminants in
developing countries. It is estimated that around four
billion persons are to some extent chronically exposed
to aflatoxins. There are four major aflatoxins (B1, B2, G1
and G2) produced by filamentous fungi of the genus
Aspergillus [14]. AFB1, the most potent hepatocarcino-
genic compound of the family, is converted in human
organism by selected isoforms of cytochrome P450 (e.g.
CYP1A2, CYP3A4) in aflatoxin-8,9-epoxide that react
with DNA or proteins to form adducts [15]. Aflatoxin
M1, the major metabolite commonly found in urine or
breast milk of mammals, has ten times less carcinogenic
potency than AFB1. Acute toxicity of AFB1 is frequent
in animals but is rarely observed in humans except for
children. The major symptom of acute aflatoxicosis is
the hemorrhagic necrosis of the liver [16]. In areas
where exposure to AFB1 is chronic, mutations of TP53
on the codon 249 (ARG > SER) are found in up to 50 %
of cases. These mutations are considered, therefore, as a
fingerprint of AFB1 activity [17].
Ivory Coast is located in West Africa along the Gulf of
Guinea shores. The country is characterized by the high-
est environmental diversity in West Africa (mangrove
swamps, forests, mountains and savannas) [18]. Popula-
tion comprises more than 60 linguistic groups that can
be regrouped in 4 major ethnicities (Akan and Kru in
the South, Mandé and Gur in the North of the country)
[19]. Due to the impact of the environment and lifestyle
on human liver tumorigenesis, some degree hetero-
geneity in the natural history of tumorigenesis can be
expected in Ivory Coast. Early reports have described the
clinical features of HCC in Ivory Coast. In the 1960–70decades, these tumors were characterized by a very high
sex ratio (M:F = 10-20), a younger mean age of onset
(42–47 years old), a high rate of associated cirrhosis,
and a low socio-economic status of the patients. An
instrumental role of the AFB1 was heavily suspected at
that time [20–23]. In addition, early molecular analyses
have shown that HBV DNA integration played a major
role in liver tumorigenesis [24, 25]. More recently, the
sex ratio had decreased significantly (M:F = 3) whereas
the mean age of tumor onset was stable (47 yo) regard-
ing the previous reports [26]. In the recent period, liver
cancer still ranked at the 2nd and 4th position for men
and women in Ivory Coast [27].
Viral, nutritional or environmental risk factors (RFs) of
HCC in Ivorian patients are suspected to have changed
due to the major demographic, economical and environ-
mental evolution that affects Ivorian populations for the
last decades. To assess whether the epidemiological
bases of liver tumorigenesis drifted during the last
decades in Ivory Coast, we set out to evaluate the role
played by common RFs in patients with HCC. Preliminary
results indicate that substantial changes had occurred in
Ivory Coast regarding risk factors of HCC. This situation
prompted us to present our data as a warning signal to
Public Health authorities.
Results
Demographic and lifestyle data
Out of 40 patients with HCC who were interviewed
during the study period (June 2011-December 2012), 30
(75 %) accepted to participate to the current survey: 22
men and eight women (sex ratio of 2.75, see Table 1).
Mean age was 53.7 ± 15.8 years (range 27–82, see
Fig. 1a). Overall, 5 (16.7 %) patients lived in a dwelling
sheltering more than 2 persons per room, a condition
corresponding to low socioeconomic status according to
local standards (http://www.ins.ci). Patients were born in
the four major ethno-linguistic areas of the country
without significant difference regarding the distribution
of these groups in the general Ivorian population (see
Fig. 1b) [28]. Foreigners were less represented than
expected (10 vs 27 %). 15 out of the 19 regions (79 %) of
the country were represented among the birthplaces of
the patients (see Fig. 2).
Lifestyle features commonly associated with an in-
creased risk of HCC were analyzed. Heavy drinking
(>200 g ethanol/week for men, >100 g for women) was
reported for seven patients (23.3 %) whereas a history of
tobacco use was found in only three of them (10 %, see
Table 1). Regarding nutritional RFs, major subsets of
patients (53.3-66.7 %) commonly consumed peanuts and
maize, two commodities known as heavily contaminated
with AFB1 in Ivory Coast [29]. Remarkably, peanut con-
sumers were frequently maize flour user as well (70 % of





Median age, yr (IQRa) 53.7 (43–64)
Low socio-economical standardb n (%) 5 (16.7)
Living in Abidjan n (%) 18 (60.0)
Ethnical origin
Akan-speaking areas n (%) 11 (36.6)
Gur-speaking areas n (%) 5 16.6)
Kru-speaking areas n (%) 4 (13.3)
Mandé-speaking areas n (%) 7 (23.3)
Foreign born (Burkina Faso) n (%) 3 (10.0)
Lifestyle features
History of heavy drinking n (%) 7 (23.3)
Tobacco use n (%) 3 (10.0)
Cassava consumption n (%) 19 (63.3)
Maize flour consumption n (%) 16 (53.3)
Peanut consumption n (%) 20 (66.7)
Risk factors of infection
Dental treatment n (%) 8 (26.6)
Invasive medical practicesc n (%) 11 (36.6)
Ritual scarifications n (%) 12 (40.0)
Sex-transmitted infections n (%) 3 (10.0)
Clinical features
Metabolic disease (Type 2 diabetes, obesity) n (%) 6 (20.0)
Hepatomegaly n (%) 25 (83.3)
Jaundice n (%) 21 (70.0)
Bruises n (%) 7 (23.3)
Portal anastomoses n (%) 5 (16.6)
Liver pain n (%) 20 (66.7)
Ascites n (%) 21 (70.0)
Multi-nodular tumors n (%) 27 (90.0)
ECOG clinical stage**** n (%)
- 1 or 2 8 (26.7)
- 3 or 4 22 (73.3)
Biochemistry
Alpha-feotoprotein >400 ng/mL n (%) 13 (43.3)
Hemoglobin (g/dL ± SD) 10.2 ± 2.0
Prothrombin ratio (% ± SD) 69.3 ± 20.5
ASAT (UI/mL, mean ± SEM) 211 ± 45
ALAT (UI/mL, mean ± SEM) 143 ± 26
aIQR = Interquartile range; b6 persons living in <3 rooms-house
c: transfusion, surgery, drug dispensation with non disposable syringes
****ECOG = Eastern Cooperative Oncology Group
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peanut (only 20 % were using maize flour, P = 0.018).
Exploring the risks of infection, we observed that 11
(36.6 %) of patients have been subjected to invasive
medical practices commonly associated with a high risk of
viral contamination in developing countries (blood expos-
ure accidents, blood transfusions, etc.…, see Table 1).
Traditional scarifications, found in 40 % of cases (n = 12),
were present in older patients (60 ± 16 vs 49 ± 13 yo,
P = 0.062, NS), suggesting that this tradition is maybe
currently waning in the country. Finally, metabolic risk
factors (type 2 diabetes and obesity) were found in only
six patients (20 %). These patients were significantly
older than the others (62 ± 4 vs 51 ± 17 y.o., P = 0.02).
Clinico-biological features
The clinical records of the series correspond to very
advanced tumors. HCC was multi-nodular in 90 % of the
cases; hepatomegaly was present in 83 %, ascites in 66 %,
and jaundice in 70 %. The distribution according to the
ECOG clinical stages were one patient (3.3 %), seven pa-
tients (23.3 %), 16 patients (53.3 %), and six patients (20 %)
respectively at stages 1, 2, 3, and 4 (see Table 1) [30].
Concerning laboratory test, AFP was measured above
a level 400 UI/mL in 43.3 % of cases. Younger patients
(1st quartile) were more frequently high AFP expressers
than older ones (86 vs 31 %, P = 0.027, see Additional file 1:
Figure S1A). No women were displaying AFP above the
diagnostic threshold. This difference was statistically
significant with regard to males (0 vs 52 %, p = 0.011,
see Additional file 1: Figure S1B). Aminotransferases
were determined for 24 patients with abnormalities in
all (100 %) cases (Table 1).
Virological data
HBsAg and anti-HCV antibodies (Ab) were reactive for
19 (63.3 %) and 14 patients (46.6 %). Overall, 25 (83.3 %)
of HCC patients were infected either with HBV or HCV.
Co-infection (HBV–HCV) was observed in eight cases
(26.6 %, see Table 2). We observed that patients carrying
anti-HCV were significantly older than other patients
(59 ± 17 vs 49 ± 13, P = 0.04, Fig. 3a). Overall, 92 % of
the patients have been exposed in their lifetime to HBV
as shown by the presence of anti-HBcAb. The early
HBV antigen (HBeAg), signing active viral replication, was
found in five chronic carriers only (26.6 % of chronic car-
riers) whereas HBV DNA was detected by PCR in 14 cases
(73.6 % of HBsAg carriers). All isolates (n = 14/14,
100.0 %) were scored as genotype E. Viral loads in positive
samples ranged from 50 and 500 000 copies/mL.
Statistical differences were found between HBsAg(+)
and other patients. Chronic HBV-infection (HBsAg(+))
was significantly associated with elevation of aminotrans-
ferases (210 ± 180 vs 97 ± 67 for ASAT and 130 ± 110 vs
Fig. 1 a-Distribution of HCC cases, according to age. b-Maternal language distribution in patients with HCC. The general linguistic distribution in
Ivory Coast was obtained from Biekanh FK [28]
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Fig. 3b) indicating that, in its terminal phases, chronic
infection with HBV is more active than hepatitis C in
Ivory Coast. None of the other serological or molecular
viral biomarkers were associated with a significant ami-
notransferases elevation. As expected, aminotransferases
levels were normal or sub-normal in nonB and nonCFig. 2 Regions of origin of the 30 patients with HCC. A conspicuous lack of ca
Fromager and Lacs/Lakes)HCC patients, showing significantly lower levels than
those observed in infected patients (e.g. ALAT, 39 ± 14 vs
170 ± 134, P = 0.0005, see Additional file 1: Figure S1C).
Epidemiological correlations
In the current series, the place of living (in or outside
of Abidjan) was correlated with specific features. Weses is observed in median regions of the country (Bafing, Moyen-Cavally,
Table 2 Viral risk factors in the 30 patients with HCC




anti-hepatitis B immunization 3 (10.0)
anti-HCV (+) 14 (46.6)
Co-infection HBsAg(+)/anti-HCV(+) 8 (26.6)
HBV DNA (+) 14 (46.6)
Genotype E 14/14 (100.0)
n represents the number of positive samples. Percentages are given for the 30
patients except for HBV genotype
Fig. 3 a-Anti-HCV(+) patients are older than anti-HCV(−). Age distribution o
is more important in case of chronic infection with HBV (HBsAg(+)) than in
than those coming from other regions of the country. d-Patients living outsid
regions (Gur and Mandé-speaking) or northern neighboring country (Burkina
born in the north are more frequently maize consumers
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cantly younger than patients living elsewhere in the
country (48 ± 14 vs 60 ± 16 y.o., P = 0.038, Fig. 3c). In
addition, Anti-HCV was found in 83 % of outside
Abidjan-living patients, a figure much higher than the
23 % rate observed in Abijanese individuals (P = 0.002,
Fig. 3d). Patients living in Abidjan were also more often
positive for HBsAg than others albeit non significantly
(61 vs 33 %, ns).
Likewise ethno-linguistic background was correlated
with a specific pattern of HCC in Ivory Coast. Patients
born in Mandé- and Gur-speaking regions (North) or in
Burkina Faso (a neighboring country on the northern
border) were significantly younger than patients born
in the South (Akan and Kru) of the country (48 ± 14 vs
59 ± 15, P = 0.05, Fig. 3e). Interestingly, these obser-
vations correlated with the fact that Mandé and Gur
speaking patients were more frequently consumers off HBsAg(+) and (−) patients is shown for comparison. b-Liver damage
the case of chronic hepatitis C. c-Patients living in Abidjan are younger
e Abidjan are more often anti-HCV carriers. e-Patients born in northern
Faso) are younger than those born in the southern Ivory Coast. f-Patients
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P = 0.009, Fig. 3f ). Furthermore, we observed that maize
flour consumption tended to be associated with significant
liver damage as shown by the increase of aminotransfer-
ases (ASAT, 296 ± 252 vs 126 ± 92, P = 0.06, NS, see Fig. 4).
Finally, viral RFs are not evenly distributed in Ivorian
HCC patients. Indeed, anti-HCV tended to be less
prevalent in patients born in Mandé and Gur-speaking
regions than in patients from southern provinces (26 vs
67 %, P = 0.066, NS).
Discussion
As emphasized by several authors, HCC occupies until
the current period a position of major importance in
cancer epidemiology of Ivory Coast. However, no etio-
logical research had been conducted in the country
since almost four decades [22, 27, 31]. Amazingly, the
lack of information is rather similar to the five neigh-
boring countries (Liberia, Guinea, Mali, Burkina Faso
and Ghana), a situation that prevents the development
of appropriate Public Health measures aiming at the re-
duction of HCC incidence. We present there the first
Ivorian pilot study exploring the impact on HCC of the
two major viruses responsible of chronic hepatitis virus.
Furthermore, we tried to correlate the role of the viruses
with nutritional, demographic and ethno-linguistic fea-
tures historically considered as relevant variables modulat-
ing HCC development in the country [20–22].
The mean age of the patients was 53.7 ± 15.8 years
(range 27–82) suggesting that HCC onset in the 2010s
decade is delayed when compared to the 1970s and
1990s periods where it was diagnosed around the age of 42
and 47 years [26]. The mean age value observed in IvoryFig. 4 Liver damage as measured by blood aspartate aminotransferase leve
Maize flour appears as more directly hepatotoxic than the other commoditCoast is similar to that reported from Mali (52 ± 14 y.o.)
or Nigeria (50 ± 17 y.o) but higher than that observed in
Burkina Faso (45 ± 12 y.o.) [32–34]. Similarly to a recent
observation made in Mali, the incidence peaks were
differing between sexes (5th and 7th decades of life in
males and females respectively) [35]. The low sex ratio
(M:F = 2.75), rather unusual for an African series, may,
therefore, partly explain the observed high mean age
value. In the present study, 16.7 % (5/30) of patients are
living in habitations sheltering more than two persons
per room, a promiscuity known to promote intra-
familial transmission of hepatitis B and C viruses. These
data corroborate the literature stating that HCC has a
high incidence in the low-income strata of populations
[22, 32]. It is generally considered that the early years of
life are particularly important in the history of HCC for
Sub-Saharan African patients. Indeed, chronic HBV
infection in toddlers and exposure to AFB1 through
breast milk are two major factors of HCC development
to which African children are exposed massively
[36, 37]. Therefore, the origin of patients represents a
crucial information to analyze HCC epidemiology in a
given African country. In the present series, patients
were born in 15 out of the 19 regions of the countries.
Examination of the map suggests that patients were
coming from two major macro-regions, the northern
and the southeastern areas separated by a median terri-
tory were HCC appears putatively less frequent (see
Fig. 2). This observation should be, of course, confirmed
on much larger series of Ivorian patients.
Patients included in the present report were displaying
striking differences according to the place where they
live. Patients living in Abidjan, regardless of their placels after stratification of patients according to staple food consumption.
ies investigated
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significantly younger than patients living elsewhere in
Ivory Coast. Causes explaining such drastic difference
are unknown. The hypothesis of a diagnostic bias with
preferentially old patients coming from Ivorian prov-
inces to get treated in Abidjan does not seem plausible.
The presence of environmental conditions/agents accel-
erating the pathological process in a large city as Abidjan
(12.7 million habitants in 2011, 4th largest city of Sub-
Saharan Africa) represents an alternative hypothesis sub-
stantiated by the fact that 4/5 HCC patients without
viral RF are living in Abidjan. Remarkably, there is an
abundant literature indicating that a preoccupying pol-
lution prevails in Abidjan [38–40]. Another possibility
would be a restricted access of the urban dwellers to
high quality foodstuffs rich in micronutrients control-
ling genomic integrity (folates, cobalamine, niacin and
zinc) [41]. Finally, although it was not significant, it is
worth mentioning that patients from Abidjan were more
often HBsAg(+). As a chronic infection with HBV is often
the results of newborns or toddlers contamination, it is
probable that tumorigenic process began in childhood for
these patients, explaining the early appearance of HCC.
The rate of HBsAg(+) HCC patients in the current
series (63 %) was similar to those observed historically
in the region (55-75 %) [26, 42, 43]. Genotype E of HBV
was the only genotype observed in the present series.
This genotype, endemic to Western and Central Africa,
is known to be dominant (>85 %) in Ivory Coast [44]. It
is well known that HBV genotype modulate liver tumori-
genesis as it was consistently observed in East Asia
where genotype C is more frequently associated with
HCC than genotype B [45]. In Africa, genotype E is gen-
erally considered as benign when compared to genotype
A [46, 47]. Data regarding HCV are far less abundant,
but the figure presented therein (46 %) stand well above
the corresponding levels published so far in the region
(13 and 26 % in Burkina Faso and Mali respectively) [33, 48].
Interestingly, living in Abidjan was associated with a
lesser rate of HCV infection. There was no significant
difference associated with the risks of infection (dental
treatment, ritual scarifications, invasive medical prac-
tices) investigated between Abidjan dwellers and other
patients. Presence in Abidjan of high-standard medical
institutions may explain that the iatrogenic HCV trans-
mission is less frequent in the city than in other prov-
inces of the country. Reciprocally, the relative lack of
health professionals in the provinces may conduct pa-
tients to consult traditional practitioners less aware of
infectious risks associated with the use of non-disposable
instruments. Anyhow, the issue of HCV presence at such
high levels in the Ivorian population of patients with
terminal liver disease deserves further investigation to pre-
cisely identify the modes of viral transmission.Another striking feature of the present series was the
younger age of patients born in Mandé- and Gur-speaking
areas (North) when compared to Akran/Kru (South). As
there was no significant difference regarding ethno-
linguistic backgrounds and the presence of chronic
hepatitis biomarkers, we turned our attention towards
nutritional habits. We observed that patients born in
Mandé/Gur-speaking regions were more frequent maize
consumers than patients from Akan/Kru regions. Re-
markably, our observation that, at variance with peanuts
or cassava, maize flour consumption was associated
with increased aminotransferases values, suggests that
this staple-food may be contaminated by hepatotoxic
compounds. In Sub-Saharan Africa, AFB1 is a well-
known acute and chronic liver poison. A recently
published meta-analysis estimates to 23 % the aflatoxin-
related population attributable risk of HCC in the
regions where the mycotoxin is abundant [49–51]. The
daily level of human exposure to aflatoxin in tropical
Africa ranges between 3 and 200 ng/kg [52]. It has been
historically suspected that peanuts are the primary
responsible for AFB1 intoxication in West Africa. To our
knowledge, it is the first time that amino-transferases
levels are correlated with maize flour consumption in
HCC patients from West Africa. Interestingly, recent
reports from Burkina Faso, Mali, Benin and Togo indicate
that maize is currently more heavily contaminated by
AFB1 than peanuts or autochthonous cereals [36, 53, 54].
Our results confirm these observations and suggests that
the attention of Ivorian public health authorities should be
now shifted on maize.
Conclusions
The present pilot study of HCC in Ivory Coast is the
first aetiological survey since several decades and pro-
duces a somewhat unexpected landscape of this disease
in the country. The major information concerns the
particularly high rate of infection with HCV (43 %) in
Ivorian HCC patients, a level unusual in West Africa,
historically dominated by HBV. We observed that this
situation is more particularly worrisome outside of
Abidjan. Another remarkable feature questioning the
distribution of risk factors in the Ivorian population is
the young age of two subsets of patients: Mandé/
Gur-speaking areas born (North) and Abidjan-living.
The young age of Mandé/Gur-speaking patients was
plausibly linked to a higher rate of maize consumption, a
food known as heavily contaminated by AFB1 but
massively introduced in regimens of West Africans in
the recent period. The case of Abidjan dwellers was
unforeseen but might be related to an easier access to
strong alcoholic liquors, or to the important levels of
environmental pollution described in the “Lagunes”
(lagoons) region where is located the biggest city of Ivory
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have to be cautious regarding conclusions, however, a lar-
ger scale epidemiological study is now clearly warranted to
confirm our observations and to take appropriate measures
in the domains of prevention and diagnostics.
Materials and methods
Patients
This is a multicenter cross sectional study conducted in
Abidjan, Ivory Coast and approved by the Ivorian Ministry
of Health Ethics committee. All included patients provided
written informed consent. We included all adult patients
willing to participate and diagnosed with HCC in one of
the four sites identified for the study over the period
June 2011 to December 2012. The four recruitment
centers were the followings: Cancerology Registry of
Treichville Teaching hospital, General Medicine De-
partment of Treichville Teaching hospital, General
Medicine Department of Yopougon Teaching hospital,
and General Medicine Department of Cocody Teaching
hospital. HCC was diagnosed based on clinical criteria,
imagery (ultrasound scanning), determination of the
tumour marker alpha–foetoprotein (AFP) and biochemical
assessment of liver functions (serum aminotransferases).
Out of the 30 patients recruited, 23 (77 %) had AFP deter-
mination. Socio-demographical data, clinical history and
physical examination data were collected using a standard-
ized questionnaire. Blood samples for serological analyses
were collected and sent on ice packs to the Institut
Pasteur. Sera were stored at −20 °C until assayed.
HBV and HCV serologies
HBsAg and anti-HCV were assayed using the Architect®
kit (Abbott Diagnostics, Wiesbaden, Germany) accord-
ing to manufacturer’s instruction. In house positive and
negative controls sera were introduced in each EIA run
for internal quality control.
HBV DNA extraction
DNA was extracted from 500 μl of serum using the
Promega Cat # A1125 DNA purification kit (Madison,
WI, USA), according to manufacturer’s instructions, and
eluted in 100 μl of buffer.
Genotyping
A PCR was performed according to the method of Naito
et al. to select samples containing HBV DNA. Positive
PCR was subjected to genotyping assay [55]. A genotyp-
ing system based on multiplex-nested PCR using type-
specific primers were employed in assigning genotypes
A through F based on pre-S1through S genes of the
HBV genome. The sequences of PCR primers used in
this study are shown in Additional file 2: Table S1. The
P1 and S1-2 were universal outer primers. Primer B2was used as the inner sense primer with a combination
of other anti-sense primers for genotypes A, B, and C in
a multiplexing system called “Mix A”. Primer B2R was
used as the anti-sense inner primer with a combination
of sense primers for genotypes D, E and F in a multiplex
system called “Mix B”. The genotype-specific primers
were relying on sequence conservation within a geno-
type and poor homology with the sequences derived
from other HBV genotypes.Real-time PCR quantification of HBV DNA
Viral DNA was purified before quantification. The
Nuclisens magnetic extraction protocol (BioMerieux,
France) was used to perform this purification: 200–
500 μl of plasma and 40 μl of silica were added to 1 ml
of lysis buffer; the solution was incubated 10 min at
room temperature. Then, it was centrifuged 1 min and
the pellet was rinsed with different washing buffers by
magnetic stirring in Minimag (BioMerieux). 50 μl DNA
were eluted and stored at −20 °C or used immediately in
molecular test.
After purification, Viral DNA was quantified by real-time
quantitative PCR (qPCR) using 7500 Applied Biosystems.
The reaction mixture contained 1XGo-Taq Flexi-buffer
(Promega, Germany), 1.25 mM MgCl2, Rox dye (Invitro-
gen, California), 1Unit Go-Taq DNA polymerase, 0.25 mM
dNTPs (Promega, Germany), 0.375 μM each primer
(hbv305, hbv460), 0.25 μM Probe (15) labeled with car-
boxyfluorescein (FAM) at the 5’end and with N,N,N,
N-tetramethylrhodamine (TAMRA) at the 3’end. The
final reaction volume was 20 μl containing 5 μl of
extracted viral DNA and 15 μl of PCR-mix. Negative
controls were performed with 5 μl of sterile RNase free-
water. The amplification was performed according to
the following program: 95 °C for 10 min; followed by
40 cycles of amplification at 95 °C for 15 s, 55 °C for
30 s. Fluorescence of FAM liberated from the probe by
TaqMan was measured to determine the amplification
threshold cycle (Ct), which was the first cycle at which
fluorescent emission was 10-fold higher than the standard
deviation of the mean baseline emission. HBV-DNA was
serial diluted to concentrations of 500.000, 50.000, 50.00,
5.00, 50 and 5 IU/ml, corresponding to 14.106 -14 copies
per reaction, respectively (Additional file 3: Table S2).Statistical analysis
In univariate analysis, we compared the differences be-
tween patient subsets using the Pearson chi2 test or the
Fisher exact test. Variables included were: age, gender,
HBV genotype, and the virus loads for HBV. All vari-
ables with “P” value under 0.05 were scored as statisti-
cally significant. Statistical analysis was performed using
SPSS11.5 statistical package.
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Additional file 1: Figure S1. A. Proportion of Ivorian patients with AFP
levels above the diagnostic threshold (400ng/mL) after stratification for
age. B. Gender difference for diagnostic AFP levels. C. Aminotransferase
levels in virus-associated and non-viral HCC cases.
Additional file 2: Table S1. Sequences of primers used for this study.
Additional file 3: Table S2. Clinical linear dynamic range of real time
VHB PCR.
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